Drag a card by its title · ⚙ to size, swap or remove

The company

Whitehawk Therapeutics, Inc.

WHWK · Nasdaq

Health CareBiotechnologyNot moving yet

WHWK stood above a rising 150-day average in 47 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 26.0% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 5
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $5.2M
Officials’ trades on record: 0
Institutions holding: 76 (+18)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 47 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months14

Buyers · sellers0 · 3

Who	Did	Shares	Traded
Scott M. GiacobelloCHIEF FINANCIAL OFFICER	sold	141,600at $4.13	16 Apr 2026filed 17 Apr 2026
Scott M. GiacobelloCHIEF FINANCIAL OFFICER	sold	77,000at $3.86	15 Apr 2026filed 17 Apr 2026
Bryan BallSee remarks	sold	92,460at $3.64	14 Apr 2026filed 15 Apr 2026
Bryan BallSee remarks	sold	26,389at $3.46	13 Apr 2026filed 15 Apr 2026
Bryan BallSee remarks	sold	6,596at $3.43	10 Apr 2026filed 13 Apr 2026
Bryan BallSee remarks	sold	50,000at $3.57	9 Apr 2026filed 13 Apr 2026
David James LennonCHIEF EXECUTIVE OFFICER	sold	14,500at $3.38	9 Apr 2026filed 10 Apr 2026
David James LennonCHIEF EXECUTIVE OFFICER	sold	63,945at $3.40	8 Apr 2026filed 8 Apr 2026
David James LennonCHIEF EXECUTIVE OFFICER	sold	94,087at $3.43	7 Apr 2026filed 8 Apr 2026
David James LennonCHIEF EXECUTIVE OFFICER	sold	102,395at $3.51	6 Apr 2026filed 8 Apr 2026
David James LennonCHIEF EXECUTIVE OFFICER	sold	26,858at $3.48	2 Apr 2026filed 3 Apr 2026
Scott M. GiacobelloCHIEF FINANCIAL OFFICER	sold	2,594at $3.31	2 Mar 2026filed 10 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders76+18 on the quarter

New · exited29 · 11

Reported value$197.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Yu Fanadded · filed 14 Aug 2026	4,861,314$22.3M	+2,791,314+134.8%
ACUTA CAPITAL PARTNERS, LLCadded · filed 14 Aug 2026	4,685,912$21.5M	+1,275,510+37.4%
QVT Financial LPunchanged · filed 14 Aug 2026	4,615,709$21.1M	00.0%
MONTANOVA CAPITAL, LLCadded · filed 14 Aug 2026	4,300,000$19.7M	+600,000+16.2%
ORBIMED ADVISORS LLCreduced · filed 14 Aug 2026	3,934,296$18.0M	-231,704−5.6%
Avoro Capital Advisors LLCunchanged · filed 14 Aug 2026	2,849,402$13.1M	00.0%
Siren, L.L.C.added · filed 13 Aug 2026	2,337,102$10.7M	+255,102+12.3%
KVP Capital Advisors, LPunchanged · filed 13 Aug 2026	2,165,997$9.9M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	1,922,828$8.8M	+1,571,443+447.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,388,561$6.4M	+72,791+5.5%